Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells

Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells

US Patent 11464806 · Granted Oct 11, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinos2016
Expansion medium for CD34-negative stem cells2013
CD34 stem cell-related methods and compositions2011
Genetically modified CD34-negative adherently growing stem cells and their use i2002